Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
  1. 2021
  2. Published
  3. 2020
  4. Published

    Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer

    Westergaard, M. C. W., Milne, K., Pedersen, M., Hasselager, T., Olsen, L. R., Anglesio, M. S., Borch, T. H., Kennedy, M., Briggs, G., Ledoux, S., Kreuzinger, C., Decken, I. V. D., Donia, M., Castillo-Tong, D. C., Nelson, B. H. & Svane, I. M., 18 Dec 2020, In: Cancers. 12, 12

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer

    Kverneland, A. H., Pedersen, M., Westergaard, M. C. W., Nielsen, M., Borch, T. H., Olsen, L. R., Aasbjerg, G., Santegoets, S. J., van der Burg, S. H., Milne, K., Nelson, B. H., Met, Ö., Donia, M. & Svane, I. M., 2 Jun 2020, In: Oncotarget. 11, 22, p. 2092-2105 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer

    Friese, C., Harbst, K., Borch, T. H., Westergaard, M. C. W., Pedersen, M., Kverneland, A., Jönsson, G., Donia, M., Svane, I. M. & Met, Ö., 3 Mar 2020, In: Scientific Reports. 10, 1, p. 3914 3914.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. 2019
  8. Published
  9. Published
  10. Published

    Tumour-reactive T cell subsets in the microenvironment of ovarian cancer

    Westergaard, M. C. W., Andersen, R., Chong, C., Kjeldsen, J. W., Pedersen, M., Friese, C., Hasselager, T., Lajer, H., Coukos, G., Bassani-Sternberg, M., Donia, M. & Svane, I. M., 19 Feb 2019, In: British Journal of Cancer. 120, 4, p. 424-434 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. 2018
  12. Published

    Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study

    Pedersen, M., Westergaard, M. C. W., Milne, K., Nielsen, M., Borch, T. H., Poulsen, L. G., Hendel, H. W., Kennedy, M., Briggs, G., Ledoux, S., Nøttrup, T. J., Andersen, P., Hasselager, T., Met, Ö., Nelson, B. H., Donia, M. & Svane, I. M., 2018, In: OncoImmunology. 7, 12, p. e1502905

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. 2017
  14. Published
  15. Published

    Cancer immunotherapy in patients with preexisting autoimmune disorders

    Donia, M., Pedersen, M. & Svane, I. M., Apr 2017, In: Seminars in Immunopathology. 39, 3, p. 333-337 6 p.

    Research output: Contribution to journalReviewResearchpeer-review

  16. Published
  17. 2015
  18. Published

    Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma

    Andersen, R., Donia, M., Westergaard, M. C. W., Pedersen, M., Hansen, M. & Svane, I. M., 2 Dec 2015, In: Human vaccines & immunotherapeutics. 11, 12, p. 2790-5 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    The Stop-Only-While-Shocking algorithm reduces hands-off time by 17% during cardiopulmonary resuscitation - a simulation study

    Koch Hansen, L., Mohammed, A., Pedersen, M., Folkestad, L., Brodersen, J., Hey, T., Lyhne Christensen, N., Carter-Storch, R., Bendix, K., Hansen, M. R. & Brabrand, M., 4 May 2015, In: European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. 2014
  21. Published
  22. Published

    One fourth of acutely admitted patients use over-the-counter-drugs 24 hours prior to hospitalisation

    Pedersen, M. & Brabrand, M., Feb 2014, In: Danish Medical Bulletin (Online). 61, 2, p. A4789

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 44377700